The Valley Desk

NCT03462342 · Interventional trial

Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer

Overall registry status Completed

Phase 2

Conditions High Grade Serous Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov